Microbiome Assessment for Cervical Disc Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
Patients who are about to undergo cervical fusion surgery at Hospital for Special Surgery (HSS) are being asked to take part in this research study. The purpose of this study is to better understand the presence of bacteria in cervical spine surgery, using next-generation sequencing to identify bacteria in swab samples. A total of 76 participants will take part in this study at HSS.
Who Is on the Research Team?
Frank P Cammisa, MD
Principal Investigator
Hospital for Special Surgery, New York
Are You a Good Fit for This Trial?
This trial is for adults scheduled to have cervical fusion surgery at Hospital for Special Surgery due to conditions like degenerative disc disease, radiculopathy, or spinal stenosis. Specific inclusion and exclusion criteria are not detailed.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Primary Anterior Cervical Discectomy Procedures
Trial Overview
The study collects swab samples during anterior cervical discectomy (neck spine surgery) to analyze the types of bacteria present using advanced genetic sequencing methods. No new treatments or drugs are being tested.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Adults undergoing primary anterior cervical discectomy and fusion (ACDF) involving one to three contiguous cervical levels. Clinical swabs will be collected from the surgical site during surgery and analyzed by standard microbiologic culture and by metagenomic next-generation sequencing (mNGS).
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hospital for Special Surgery, New York
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.